ELTP - Elite Pharmaceuticals GAAP EPS of $0.00 revenue of $7.7M August, 15 2022 05:00 PM Elite Pharmaceuticals Inc. Elite Pharmaceuticals press release ( OTCQB:ELTP ): Q1 GAAP EPS of $0.00. Revenue of $7.7M (+2.7% Y/Y). For further details see: Elite Pharmaceuticals GAAP EPS of $0.00, revenue of $7.7M